Search Within

Joachim Yahalom

  1. "2020"
Formats
  1. Journal Article (8)
  2. Meeting Abstract (6)
  3. Review (3)
  4. Correspondence (2)
  5. Editorial (2)
  6. Guidelines (2)
  7. Research Letter (1)
Groups
  1. Radiation Oncology, Department of (24)
  2. Survivorship Research (24)
  3. Department of Medicine (13)
  4. Hematologic Malignancies, Division of (13)
  5. Center for Hematologic Malignancies (12)
  6. Lymphoma (11)

More Groups

People
  1. Alison Moskowitz (7)
  2. Connie Batlevi (7)
  3. Steven Horwitz (7)
  4. Ariela Noy (6)
  5. Brandon Imber (6)
  6. Maria Palomba (6)

More People

Years
  1. 2020 (24)
Publications
  1. International Journal of Radiation Oncology, Biology, Physics (6)
  2. Blood (4)
  3. Blood Advances (3)
  4. Journal of Clinical Oncology (2)
  5. Leukemia and Lymphoma (2)
  6. British Journal of Haematology (1)

More Publications

Publishers
  1. American Society of Hematology (7)
  2. Elsevier Inc. (7)
  3. American Society of Clinical Oncology (2)
  4. Lippincott Williams & Wilkins (2)
  5. Springer (2)
  6. Taylor & Francis Group (2)

More Publishers

Results (24)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Outcomes in patients with DLBCL treated with commercial CAR T cells compared with alternate therapies
    Journal Article

    Sermer, D.; Batlevi, C.; Lia Palomba, M.; Shah, G.; Lin, R. J.; Perales, M. A.; Scordo, M.; Dahi, P.; Pennisi, M.; Afuye, A.; more...
    Blood Advances (2020)

    Fulltext@MSK | Save
  • Extra copies of MYC, BCL2, and BCL6 and outcome in patients with diffuse large B-cell lymphoma
    Journal Article

    Sermer, D.; Bobillo, S.; Dogan, A.; Zhang, Y.; Seshan, V.; Lavery, J. A.; Batlevi, C.; Caron, P.; Hamilton, A.; Hamlin, P.; more...
    Blood Advances (2020)

    Fulltext@MSK | Save
  • Early experience using salvage radiotherapy for relapsed/refractory non-Hodgkin lymphomas after CD19 chimeric antigen receptor (CAR) T cell therapy
    Journal Article

    Imber, B. S.; Sadelain, M.; DeSelm, C.; Batlevi, C.; Brentjens, R. J.; Dahi, P. B.; Giralt, S.; Park, J. H.; Sauter, C.; Scordo, M.; more...
    British Journal of Haematology (2020)

    Fulltext@MSK | Save
  • Involved site radiation therapy in adult lymphomas: An overview of International Lymphoma Radiation Oncology Group guidelines
    Review

    Wirth, A.; Mikhaeel, N. G.; Aleman, B. M. P.; Pinnix, C. C.; Constine, L. S.; Ricardi, U.; Illidge, T. M.; Eich, H. T.; Hoppe, B. S.; Dabaja, B.; more...
    International Journal of Radiation Oncology, Biology, Physics (2020)

    Fulltext@MSK | Save
  • Grade 3A follicular lymphoma can be effectively controlled with very low-dose radiation therapy
    Research Letter

    Imber, B. S.; Chau, K.; Goldberg, E.; Joffe, E.; Yahalom, J.
    Leukemia and Lymphoma (2020)

    Fulltext@MSK | Save
  • NCCN Clinical Practice Guidelines in Oncology: Hodgkin lymphoma, version 2.2020
    Guidelines

    Hoppe, R. T.; Advani, R. H.; Ai, W. Z.; Ambinder, R. F.; Armand, P.; Bello, C. M.; Benitez, C. M.; Bierman, P. J.; Boughan, K. M.; Dabaja, B.; more...
    Journal of the National Comprehensive Cancer Network (2020)

    Fulltext@MSK | Save
  • Diagnostic and therapeutic considerations for extramedullary leukemia
    Review

    Bakst, R.; Powers, A.; Yahalom, J.
    Current Oncology Reports (2020)

    Fulltext@MSK | Save
  • Radiotherapy for non-Hodgkin lymphomas
    Review

    Imber, B. S.; Yahalom, J.
    The Cancer Journal (2020)

    Fulltext@MSK | Save
  • Principles of radiation therapy for Hodgkin lymphoma
    Journal Article

    Yahalom, J.; Hoppe, B. S.; Yang, J. C.; Hoppe, R. T.
    Hematologic Malignancies (2020)

    Fulltext@MSK | Save
  • Rosai-Dorfman disease - Utility of (18)F-FDG PET/CT for initial evaluation and follow-up
    Journal Article

    Mahajan, S.; Nakajima, R.; Yabe, M.; Dogan, A.; Ulaner, G. A.; Yahalom, J.; Noy, A.; Diamond, E. L.; Schòˆder, H.
    Clinical Nuclear Medicine (2020)

    Fulltext@MSK | Save